Dr. Ren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The Hub for Clinical Collaboration
3500 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-3749
Summary
- Dr. Clement Ren is a pediatric pulmonologist at the Children's Hospital of Philadelphia. He holds the Richard B. Johnston, Jr. Endowed Chair in Pediatrics and is Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice 35 years. He is experienced in pulmonary function testing, cystic fibrosis, bronchopulmonary dysplasia, pediatric pulmonology, and clinical research.
Education & Training
- University of Rochester Simon School of BusinessMBA, Medical Management, 2014 - 2016
- St Christopher's Hospital for ChildrenFellowship, Pediatric Pulmonology, 1994 - 1996
- Boston Children’s HospitalFellowship, Allergy and Immunology, 1990 - 1993
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1987 - 1990
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1987
Certifications & Licensure
- PA State Medical License 1994 - 2026
- IN State Medical License 2015 - 2021
- NY State Medical License 1996 - 2016
- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Pediatric Pulmonology Sub-Board American Board of Pediatrics, 2018
- Associate Editor Pediatric Pulmonology, 2018
- ATS Fellow American Thoracic Society, 2018
- Join now to see all
Clinical Trials
- Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies Start of enrollment: 2011 Aug 01
- Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) Start of enrollment: 2016 Oct 21
- AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Start of enrollment: 2017 Sep 20
- Join now to see all
Publications & Presentations
PubMed
- Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF.Michael S Schechter, Joshua S Ostrenga, Elizabeth A Cromwell, Clement L Ren, Aliza K Fink
Pediatric Pulmonology. 2024-12-01 - Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele.Georgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, Christopher H Goss, Raksha Jain
Journal of Cystic Fibrosis. 2024-10-28 - Lung T1 MRI assessments in children with mild cystic fibrosis lung disease.Clement L Ren, Samya Z Nasr, James E Slaven, Aparna Joshi, Maryam Ghadimi Mahani
Pediatric Pulmonology. 2024-10-01
Press Mentions
- IU-Led Study Helps Cystic Fibrosis Patients Lighten Treatment LoadAugust 30th, 2021
- IUSM Researchers Lead National StudyJune 9th, 2021
Professional Memberships
- Member
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: